Herein we describe a protocol that uses hollow-fiber flow field-flow fractionation (FFF) coupled with multiangle light scattering (Mals) for hydrodynamic size-based separation and characterization of complex protein aggregates. the fractionation method, which requires 1.5 h to run, was successfully modified from the analysis of protein aggregates, as found in simple protein mixtures, to complex aggregates, as found in total cell lysates. In contrast to other related methods (filter assay, analytical ultracentrifugation, gel electrophoresis and size-exclusion chromatography), hollow-fiber flow FFF coupled with Mals allows a flow-based fractionation of highly purified protein aggregates and simultaneous measurement of their molecular weight, r.m.s. radius and molecular conformation (e.g., round, rod-shaped, compact or relaxed). the polyethersulfone hollow fibers used, which have a 0.8-mm inner diameter, allow separation of as little as 20 mg of total cell lysates. In addition, the ability to run the samples in different denaturing and nondenaturing buffer allows defining true aggregates from artifacts, which can form during sample preparation. the protocol was set up using paraquat-induced carbonylation, a model that induces protein aggregation in cultured cells. this technique will advance the biochemical, proteomic and biophysical characterization of molecular-weight aggregates associated with protein mutations, as found in many cns degenerative diseases, or chronic oxidative stress, as found in aging, and chronic metabolic and inflammatory conditions. is observed 6, 7, [31] [32] [33] [34] [35] [36] . These modifications are known to facilitate unfolding and protein aggregation [6] [7] [8] . Last, any disease or condition that decreases the proteasome or the endosomal and lysosomal processing activity, the autophagic mechanisms or the chaperone folding machinery will increase protein aggre and huntingtin protein in gation 9, 10, 13, [37] [38] [39] [40] [41] [42] [43] [44] . In all these conditions, the ability to purify protein aggregates and to analyze their biophysical properties will enhance our knowledge of the pathogenesis of these diseases.
IntroDuctIon
Protein aggregation is a common biological phenomenon associated with several physiological and pathological conditions. Overall, protein aggregation indicates the cellular inability to maintain its own proteostasis, and it comprises the association of proteins into a larger assembly after the loss of their secondary, tertiary or quaternary structures, and it is often associated with the loss of their biological activity 1 .
There is a keen interest in analyzing protein aggregates for several reasons:
(i) To elucidate how a protein's primary and secondary structure determines its propensity to associate into larger aggregates, under either physiological or pathological conditions such as in neurodegenerative diseases (Alzheimer's, Parkinson's and Huntington's diseases) associated with amino acid mutations [2] [3] [4] [5] ; (ii) To map the post-translational oxidative modifications associated with pathologies that are known to induce protein aggregation, such as chronic inflammatory, metabolic and degenerative diseases and aging [6] [7] [8] ; and (iii) To fractionate highly purified protein aggregates of different sizes and conformation in order to analyze the different cellular machinery associated with their refolding or disposal including chaperones, autophagy-related proteins and proteasome [9] [10] [11] [12] [13] [14] [15] .
A recent review 16 that discussed the current proteomics prefractionation methods highlighted the emerging role and advantages of FFF, a flow-based separation technique invented in the 1960s by Giddings 17, 18 . Flow FFF uses a 'flow' field to accomplish the separation, which consists of a stream of mobile phase that is applied orthogonally to the elution flow. Flow FFF offers high selectivity in terms of separating proteins with different diffusion coefficients (D); this coefficient is directly proportional to a protein's size, shape/conformation and molecular weight (MW), and thus it is unique to each protein 16 (Fig. 1a,b) . The separation occurs inside an empty capillary channel, and thus the shear stress exerted on the sample is minimal, allowing the sample components to preserve their biophysical features. This feature also allows for the separation to be performed in a sample-compatible/bio-friendly carrier solution. Flow FFF is also flexible in terms of channel design, a feature that led to the development of its miniaturized version called hollow-fiber flow FFF (abbreviated HF5). The reduced volume of the HF5 device involves the use of very low flow rates, and thus a reduced sample dilution, which also made possible the on-line HF5-mass spectrometry (MS) coupling 19, 20 .
The methodology described herein can be applied to the analysis (and relative quantification) of biological samples in which protein aggregation is very relevant to the pathogenesis of the disease. Amino acid mutation is one of the causes of protein aggregation in familiar forms of neurodegenerative diseases, including the aggregation of α-synuclein in Parkinson's disease 2, 5, [21] [22] [23] , the aggregation of tau or β-amyloid in Alzheimer's disease 3, 24, 25 and huntingtin protein in Huntington's disease [26] [27] [28] [29] [30] . In addition, in chronic inflammatory and degenerative diseases and metabolic syndrome or diabetes, an increase in oxidative stress-related protein post-translational modifications, including glycation, lipoxidation and carbonylation, bacterial proteome, some HF5 method parameters were adapted to allow a single-step extensive characterization of the cellular proteome samples.
Application of the protocol
To set up the methodology, we induce protein aggregation by treating the cells with Paraquat (PQ), which reproduces the type of protein aggregation observed in chronic inflammatory and degenerative conditions and aging [6] [7] [8] .
Experimental design
The procedure is summarized in Figure 1c , and it consists of the following stages:
(i) Sample preparation (Steps [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] stage is to determine the biophysical nature of the PQ-induced protein aggregates, especially the irreversible urea-resistant covalent HMW protein aggregates. The experimental setup includes HF5-UV and MALS detection and separation of the total cell lysate, fractionation of the proteome according to the MW, data processing and interpretation. The MW ranges used to fractionate the proteome is identical to the ones used under native conditions. This provides a simple way to compare protein aggregates under native and mild denaturing conditions. Changes in MW, hydrodynamic and r.m.s. radius, as well as protein conformation, are observed when comparing the results obtained under different separation conditions.
Advantages and limitations of the protocol
Given the size of the separation device and the calculated amount of HMW protein aggregates present in the total lysates (approximated at 2-8%), fraction pooling from different runs is required in order to obtain the necessary amount of protein for further analysis (SDS-PAGE and MS). The protocol time can be reduced considerably if further complementary analyses of the separated protein aggregates are not required. On-line coupling of HF5 with UV and MALS detection is sensitive enough to fully characterize cell lysate amounts down to 20 µg of total protein (hydrodynamic size, absolute MW, r.m.s. radius, molecular conformation and relative quantification of HMW protein aggregates as the percentage of the total protein).
However, when used for semipreparative purposes, there are risks of overloading the HF5 device (Fig. 2a-c) if the total protein amount exceeds 100-150 µg. The commercial HF5 cartridge ( Fig. 1) overloads at ~50 µg of total protein amount. Aside from the double-length HF5 device used in this protocol, possible scale-up of the separation device may include the use of multiple HF5 commercial cartridges working in parallel, as described by Lee et al. 52 .
Comparison with other methods
Building on the increased interest in analyzing protein aggregates, a wide variety of analytical methods have been used to separate the aggregates, including filter assays, sedimentation velocity analytical ultracentrifugation (SV-AUC), gel electrophoresis, size-exclusion chromatography (SEC) and its macro-column variant fast protein liquid chromatography (FPLC) [57] [58] [59] [60] [61] . SV-AUC can be used for proteome samples dispersed in different media, over a wide size range of protein aggregates. Nevertheless, the analyses cannot resolve closely sized aggregates, it is timeconsuming and it has low sample throughput 62 . SEC and, by extension, FPLC are also often used to separate protein aggregates. However, protein aggregates often adsorb to the column matrix, large protein aggregates can be lost in the void volume and both techniques fail to resolve aggregates over a large dynamic range 63 . In addition, all the above-mentioned techniques cannot be performed in high-detergent concentrations or under denaturing conditions, as used to distinguish between covalent versus noncovalent protein aggregates. Finally, gel electrophoresis, which is also commonly used to separate protein aggregates, does not provide an accurate MW analysis, nor does it provide any information on the biophysical properties of the aggregates.
Therefore, an analytical methodology that is capable of accurately separating protein aggregates on the basis of their molecular size and their biophysical properties would prove to be extremely useful in the characterization of physiological and pathological protein aggregation.
The separation principle of HF5
HF5 relies on differences in diffusion coefficient (D)-which is specific to each protein and correlated with protein size (hydrodynamic radius, r h ) and MW 45 . When proteome samples are injected into the hollow fiber, they are first subjected to the action of two longitudinal flows entering from both ends of the separation device, thus having opposite directions with a typical inlet/outlet flow ratio of 20:80 (Fig. 1a) . This results in the sample being concentrated in a narrow band at the meeting point of the two streams (where the resulting longitudinal flow is null), called the focus position (Fig. 1a) . The proteome components are then subjected to two types of forces: the radial field, which moves them toward the hollow fiber wall (black arrows in Fig. 1b) , and the protein diffusion force, which moves them toward the hollow fiber center (white arrows in Fig. 1b) . The radial field force will reach equilibrium with the protein diffusive force (steady state), at a distance from the channel wall that is specific to each diffusion coefficient (D) and thus unique to each protein.
At this point, the outlet flow is switched off, and thus the inlet flow will direct the proteome components toward the channel exit, whereas the combination of the radial field force and diffusion force will maintain each protein at the specific distance from the channel wall that was previously reached at steady state (Fig. 1b) . Smaller proteins with a larger diffusion coefficient will be the first to elute, followed by the other proteome components in increasing size order. REAGENT SETUP Cell culture medium Prepare the cell culture medium by adding 10% (vol/vol) FBS, 1% (vol/vol) HEPES buffer, MEM non-essential amino acids, 1 mM sodium pyruvate, 10 U/ml penicillin and 100 µg/ml streptomycin to complete medium HyClone DMEM/high glucose. Medium can be stored at 4 °C for up to 1 month. Mild denaturing carrier solution (50 mM Tris-HCl supplemented with 150 mM NaCl and 2 M urea): add 120.12 g of urea and 8.775 g of NaCl to 33 ml of Tris-HCl 1.5 M solution, and fill it with Milli-Q water up to 1 liter. Check the pH (8.0) and filter the solution on 0.22-µm (Steritop Millipore) filter membranes. ! cautIon Always filter the carrier solution. Prepare 500 ml at a time, and store it at room temperature (24 °C). Replace the solution at least once a week. BSA standard solution Dissolve 1 mg of BSA in 1 ml of Milli-Q water to obtain a 0.1% (wt/vol) BSA solution. This standard will be used to verify periodically the proper functioning of the separation-detection system. Significant shifts in the BSA retention time or abnormal (very intense) UV and/or light-scattering peaks at the end of the run usually indicate the depletion of the hollow fiber (which will need replacing). The BSA standard's retention time is also used to correct the time delay between detectors and band broadening. BSA is a control protein with known MW, as well as an isotropic scatterer that is used to normalize or correct the intensity of the MALS detectors (diodes at 18 different angles).
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Cleaning solution for the separation-detection (HPLC-FFF-MALS)
system Prepare a 0.2% (vol/vol) solution of Triton X-100 by adding 1 ml of Triton X-100 in 500 ml of purified water (Milli-Q water). This volume should suffice for an overnight cleaning of the separation and detection system (10 h of cleaning at 0.5 ml/min). Dialysis buffer (10 mM Tris-Cl) Measure 6.67 ml of 1.5 M Tris-HCl and fill it with Milli-Q water up to 1 liter. Prepare at least 4 liters of dialysis buffer per shift. If the carrier solution (for the HF5 separation) contains urea, replace the dialysis buffer every 6 h. EQUIPMENT SETUP Overview of the HF5-UV-MALS instrument setup This setup includes typical HPLC components (degasser, pump, autosampler and DAD), as well as the FFF separation module (Eclipse DUALTEC), HF5 separation device and a MALS detector (DAWN EOS; Fig. 2 ). We recommend degassing the carrier solution to avoid false peaks in the UV and light-scattering signals. The pump flow rate is controlled through the Eclipse plug-in for ChemStation; the same plug-in is used to generate the flows inside the Eclipse DUALTEC module-flows that are necessary to perform the HF5 separation.
An autosampler delivers the sample into the HF5 device (Fig. 1a,b) . The sample enters the DAD, which sends the UV signals variation against elution time to the PC through the ChemStation software (for proteins, typically set at 215, 260 and 280 nm). Finally, the sample enters the MALS detector, which sends the UV signal (for proteins, set at 280 nm) and the light-scattering signal from all 18 angles to the PC through the Astra software. Once the HF5 run is completed, the data can be processed. The Astra software is used to calculate the sample concentration, absolute MW and the r.m.s. radius against the elution time. It is also used to determine the molecular conformation of the sample components. ISIS software is used to calculate the hydrodynamic radius from the retention time value. In highly complex samples, the hydrodynamic radius can be only estimated. HPLC and FFF module setup Make the necessary connections (tubing and cables) between the Eclipse DUALTEC FFF separation system, the HPLC components and the PC. Follow the instructions provided by the manufacturer (Superon, distributed by Wyatt Technology Europe) for ChemStation software and Eclipse plug-in installation, instrument setup and operation. Use the ChemStation chromatographic software to control the HPLC system components (autosampler and DAD), to monitor the separation and for data processing. Set the UV lamp (DAD setup) wavelengths at 280, 215 and 260 nm, which are necessary for protein detection. Use the Eclipse plug-in for ChemStation (Superon) to operate the FFF separation module according to the manufacturer's instructions. Use the ISIS software using the instructions provided with the software for FFF method simulation and optimization and for the determination of the hydrodynamic size of the proteins and protein aggregates from their specific retention times. HF5 device setup The HF5 commercial cartridge assembly and the modes of operation of the Eclipse DUALTEC system have already been previously described in recent literature 8 and in the Eclipse DUALTEC instructions manual. The protocol presented in this paper entails using a longer HF5 separation device (scale-up for semipreparative purposes), which is assembled by joining together two 17-cm-long commercial cartridges with a cap nut, resulting in a 34-cm-long channel (2 × 17 cm = 34 cm)-the double-length HF5 device (Fig. 2a-c) . Once the chasings are connected, insert a single hollow fiber membrane (34 cm long) and seal it by tightening the cap nuts at both ends (described in detail by Johann et al. 47 ). By using the double-length HF5 device, an amount of ~100-150 µg of proteome can be loaded and separated under optimal conditions. Attach the double-length HF5 device to port A on the Eclipse DUALTEC separation system according to the manufacturer's instructions, by paying attention to possible leaks. By using the Eclipse plug-in for ChemStation HPLC software, set the detector flow rate at 0.5-0.6 ml/min in Elution mode and flush the separation system (HF5-UV-MALS) with carrier solution for 1.5-2 h. This procedure, called 'system conditioning' , eliminates the air from the HF5 cartridge and helps in obtaining stable UV and light-scattering baselines.
Perform a hollow fiber conditioning run (BSA make-up run), according to the instructions provided in the Eclipse DUALTEC operation manual, by loading the appropriate HF5 method for BSA separation (found among the preset methods) and by injecting 20-30 µg of BSA standard sample (20-30 µl of 0.1% (wt/vol) standard BSA solution). This procedure is required each time the hollow fiber is replaced with a new one. Eclipse method setup for HF5 Follow the instructions provided in the Eclipse manual to set up the Eclipse HF5 method for separation of total cell lysates, which uses the device depicted in Figure 2a -c. The HF5 method parameters used in this protocol, to be set in the Eclipse method dialog box, are reported in Table 1 . Save the method and reload it before separating the cell lysates. Remember to save the method again if changes are made and to reload it before data acquisition. Do not save the method if the only parameter changing between data acquisitions is the sample volume.  crItIcal Subtract the focus and focus injection duration time from the retention time value that appears on the ChemStation report at the end of the run to obtain the true sample retention time. The corrected retention time is to be used in the ISIS calculations. MALS detector setup Make the necessary connections (tubing and cables) between the MALS detector (DAWN EOS) and the DAD, the Eclipse DUALTEC and the PC. Please refer to Astra instructions manual for instrument configuration, Astra software installation and operation. Astra method setup Follow the instructions provided by the manufacturer for the creation of new Astra methods. Create a new Astra method for BSA separation by setting the appropriate flow rates (0.35 ml/min). Check that the Astra method starts automatically when the HF5 separation starts and that the duration of the Astra method and the Eclipse method match. Perform a BSA separation and process the data (UV and light scattering) according to the manufacturer's instructions regarding baseline setting, normalization, detector delay and band broadening. The calculated MW of the BSA monomer should match the value declared on the product sheet (~67 kDa). The BSA extinction coefficient at 280 nm (ε 280 nm 0.1% ) used in the MW computation is 0.667 (ml/mg × cm). Create a new Astra method for the separation of cell lysates (flow rate: 0.5 ml/min) and import the normalization coefficients from the previous BSA run. Save the method. Spectrophotometer: calibration curve with BSA solutions Prepare the necessary dilutions using the BSA standard provided in the kit. Follow the manufacturer's instructions provided with the BCA assay kit to measure the BSA absorbance. Prepare a standard curve by plotting the average blankcorrected 562-nm measurement for each BSA standard versus its concentration in µg/ml. The standard curve will be used to determine the protein concentration of each cell lysate. proceDure cell culture • tIMInG 24 h 1| Culture Jaws II cells (CLR-11904; American Type Culture Collection) in complete medium HyClone DMEM/high glucose supplemented with 10% FBS and 1% HEPES buffer (vol/vol), MEM non-essential amino acids, 1 mM sodium pyruvate, 10 U/ml penicillin and 100 µg/ml streptomycin.  crItIcal step Use enough cells to retrieve 50 µg of total protein lysate for each run that you plan to perform. In our hands, two million cells are needed to retrieve 100 µg.
pQ treatment • tIMInG 6 h 2| Add PQ to the cells at concentrations of 0.25, 5 and 10 mM (20 million cells for each condition, in triplicate) to induce oxidative stress. Incubate PQ-treated and untreated cells at 37 °C and 5% CO 2 for 12 h. Untreated cells serve as negative controls. The protein carbonyl spectrophotometric assay (Step 12) will verify whether the PQ treatment worked. ! cautIon Take necessary precautions (i.e., work under a fume hood) when handling PQ solutions.
3|
Collect the CTR (untreated cells) and PQ-treated cells in 50-ml Falcon tubes, and centrifuge them at 220g for 6 min at room temperature.
4|
Wash the cells three times with sterile PBS and discard the supernatant, remembering to transfer them to Eppendorf tubes before the last wash.
cell lysis • tIMInG 1 h 5| Add 150-250 µl of lysis buffer freshly supplemented with 1× protease inhibitor cocktail to the cellular pellet and incubate the mixture on ice for 40 min.
6|
Centrifuge the mixture at 11,750g for 30 min at 4 °C. The cellular pellet will be visible at the bottom of the tubes.
7|
Carefully collect the supernatant for further HF5 analysis.
protein purification by enzymatic digestion with universal nuclease • tIMInG 30-40 min 8| Add universal nuclease (0.1 µl/1 ml of lysate or prepare a 1:100 dilution and add 10 µl/1 ml cell lysate) to process nucleic acids that would interfere with protein separation, and incubate the sample on ice for 30 min.  crItIcal step The universal nuclease, similar to benzonase nuclease, has much higher specificity for degrading nucleic acids (RNA and DNA: single-stranded, double-stranded, liner or circular) compared with DNase, and therefore it is the ideal choice when complete removal of nucleic acids is required during the preparation of cell lysates.
9|
Filter the lysate samples on 0.45-µm syringe (sterile) filters.  crItIcal step It is highly important to filter the purified cell lysates, not only to eliminate the digested DNA and RNA but also to avoid blocking the tubing and/or the flow cells of the detectors with large particulates during HF5-UV-MALS separation-characterization.  pause poInt The purified cell lysates can be stored at −80 °C for 1 month or at −20 °C for ~1 week. Prolonged storage increases protein carbonylation and aggregation. protein carbonyl spectrophotometric assay to confirm the effectiveness of the pQ treatment • tIMInG 1 h 12| Determine the total protein carbonyl content in the CTR and PQ-treated cell lysates spectrophotometrically by reading the absorbance of the 2,4-dinitrophenylhydrazine (DNPH)-derivatized carbonyl groups at 375 nm, according to the manufacturer's instructions provided with the OxiSelect protein carbonyl spectrophotometric assay kit.
13|
Normalize the results to the amount of total protein in each sample. An example is depicted in Figure 3a , which shows an increased amount of protein carbonyl groups proportional to the PQ molarity. This assay proves that the PQ treatment induces protein modifications (carbonylation), which are known to lead to aggregation during aging.  crItIcal step If you do not see an increase in protein carbonylation, the PQ treatment did not work.
? troublesHootInG sDs-paGe on total cell lysates to confirm the presence of protein aggregates induced by pQ treatment • tIMInG 3 h 14| Prepare the SDS-PAGE sample buffer containing 62.5 mM Tris-Cl, pH 6.8, 2% (wt/vol) SDS, 25% (vol/vol) glycerol and 0.01% (vol/vol) bromophenol blue.
15| Dilute 20 µg of total cell lysates in sample buffer, freshly supplemented with 2-mercaptoethanol, and incubate the mixture for 5 min at 110 °C.
16|
Prepare the Tris/glycine/SDS running buffer containing 25 mM Tris, 192 mM glycine and 0.1% (wt/vol) SDS, and adjust the pH to 8.3.
17|
Load the diluted lysate samples on a Mini-PROTEAN TGX gel (4-15% (wt/vol)), recommended for the MW range of 20-250 kDa.
18| Perform the electrophoretic run in Tris/glycine/SDS running buffer for 1.5 h.
19|
Re-equilibrate the gel in water for 5 min, and stain it by using the Pierce color silver stain kit (according to the procedure reported in the kit). An example of an SDS-PAGE gel performed on CTR and PQ-treated samples is reported in Figure 3b . The gel shows higher amounts of HMW protein aggregates in the PQ-treated samples as compared with the CTR sample, proportional to the PQ molarity. The gel also shows the presence of low-molecular-weight proteins (oxidative stress-related cleavage products).  crItIcal step Make sure that the purified lysate samples have been filtered (0.450-µm sterile filters) in order to avoid blocking the MALS detector flow cell and the HPLC tubing with large particulates. (Fig. 4a) .  crItIcal step Start with the CTR (untreated) sample, and then inject the PQ-treated cell lysates in increasing PQ concentrations in order to avoid contamination. Make sure not to overload the HF5 device; it has a maximum capacity of 100-150 µg of total protein. 
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Step 12 c
Step 8 An example is depicted in Figure 4a , in which the ISIS-derived hydrodynamic radius values were plotted as the bottom x-axis. These values serve as a reference when comparing results obtained under different experimental conditions.
27|
Calculate the MW range of the cell lysate from the light-scattering intensity registered by detectors 2 through 18 and the concentration signal from the UV detector (280 nm) correlated through a first-degree Zimm model, according to the instructions provided in the Astra manual. Set an average value of 1.0 (ml/mg × cm) for the extinction coefficient at 280 nm (ε 280 nm 0.1% ) in all MW calculations for the cell lysates in the Peaks tab. The peak or selection chosen for MW range calculation should start after the void peak and end with the run (it can be reduced later to display only the MW range of interest, as in Fig. 4a) . Open EasyGraph and choose 'molar mass' to display the calculated MW range. ? troublesHootInG 28| Use EasyGraph and choose 'RMS radius' to calculate the r.m.s. radius range for the cell lysate sample from the angular dependency of the scattered light correlated through a first-degree Zimm model. The results will be displayed on the screen (Fig. 4b) . ? troublesHootInG 29| Use EasyGraph and choose 'RMS conformation plot' to determine the molecular conformation of the protein aggregates. The correlation plots (conformation plots) are generated from experimental data, by plotting the r.m.s. radius values against the corresponding MW values (both in logarithmic scale). The plots are fitted linearly and the slope values are assigned to known conformation types. A slope value of 1.0 corresponds to a rod conformation, a slope value of 0.5-0.6 corresponds to a random coil conformation and a slope value of 0.33 corresponds to a sphere conformation. The trend (slope and/or change of the slope) of the molecular conformations is determined for r.m.s. radius values of >10 nm (owing to DAWN EOS instrumental range limitation), with corresponding MW values usually >1×10 6 g/mol.
Examples of correlation plots are shown in Figure 4b , and they show molecular conformation changes (the protein aggregates become more compact) caused by the PQ treatment. These conformational changes are very likely due to protein carbonylation, which is reported in Figure 3a . Moreover, the correlation plots show the presence of HMW species (>3.5 × 10 6 Da) only in the PQ-treated samples (also observed in Figs. 3b and 4d) . ? troublesHootInG 30| Calculate the relative protein aggregate amounts, as % relative to the total protein in the lysates ( Fig. 4a; table 2 ). Choose Results → Report (summary) and scroll down to Peak Results-Mass fraction (%). ? troublesHootInG create virtual protein fractions by subdividing the chromatographic space • tIMInG 1-1.5 h 31| Load the Astra acquisition files (CTR and PQ-treated samples) and subdivide the MW range into fractions by selecting the MW of interest. Set narrower fractions for (high-abundance) smaller proteins (fractions F1-F3 in Fig. 4c , which elute in the first 15 min) and larger fractions for (low-abundance) large proteins and protein aggregates (fractions F4-F6 in Fig. 4c ).
An example is shown in table 3, in which we report the complete characterization of the virtual protein fractions selected for the purpose of this protocol. All the data reported in table 3 were retrieved from the Astra Report, on the basis of the virtual fraction selections in EasyGraph, and from the hydrodynamic radius values obtained from ISIS.  crItIcal step Use the same settings for all Astra files (fraction start and end) to effectively establish differences between the untreated and PQ-treated lysate samples. ? troublesHootInG collect and pool the protein fractions for complementary analyses • tIMInG 4 d total 32| Once the virtual fraction selection is adjusted to your needs (example shown in Fig. 4c) , proceed to actual protein fraction collection for the CTR and the lysate sample treated with the highest concentration of PQ based on the timetable of fractions established at Step 29.  crItIcal step Given the reduced size of the HF5 device (Fig. 2a-c) and the low-abundance HMW protein aggregates in the cell lysates (tables 2 and 3) , combine the fractions from eight independent runs (CTR and 10 mM PQ samples).  crItIcal step Inject as much as 100-150 µg of total cell lysate for each run. Perform four or five fraction pools and clean the system by flushing the cleaning solution overnight, followed by flushing filtered water for at least 2-3 h the next morning. Once the system is clean, replace the hollow fiber and connect it to the FFF module. The PES hollow fiber will be depleted quickly after four or five runs. Perform the fiber make-up procedure with the BSA standard, according to the Eclipse instructions manual.
33|
Monitor the separation process on the PC screen and save the acquisition files. Data processing is not necessary at this point.  pause poInt Store the protein fractions in Falcon tubes at 4 °C overnight. Proceed with fraction dialysis as soon as possible.
protein fraction dialysis • tIMInG 12 h + storage time  crItIcal The proteins are eluted at 0.5 ml/min during the separation process. Consequently, when the fraction pooling is completed, the narrowest fraction (F1, 2.5 min) will contain high-abundance proteins dispersed in 10 ml of native carrier solution, whereas the largest fractions (F4-F6) will contain low-abundance protein aggregates dispersed in 40 ml of carrier solution.
34|
Load the protein fractions into Skin pleated dialysis tubing of appropriate length (MWCO: 3,500 Da, capacity of 3.7 ml/cm). Divide the large protein fractions (F4-F6, 40 ml) and load them into two dialysis tubes.
35|
Place the loaded dialysis tubes into large containers filled with 4 liters of dialysis buffer (10 mM Tris-HCl solution at pH 8.0).
36|
Dialyze overnight in order to remove the NaCl concentration.  crItIcal step Upon dialysis completion, transfer the protein fractions into Falcon tubes and freeze them at −80 °C to speed up the lyophilization process. protein fraction lyophilization • tIMInG 12-24 h  crItIcal The lyophilization of the CTR sample fractions should begin immediately after their dialysis and storage at −80 °C, on day 3 of fractions pooling, to optimize the experimental time.
37|
Place the (frozen) protein fractions into the lyophilizer.
complementary analyses: native paGe on the protein fractions • tIMInG 5 h total 38| Resuspend the lyophilized proteins in a total volume of 100 µl of Milli-Q water.
39|
Quantify the protein amount in each fraction by BCA assay (as in Step 10) .
40|
Normalize the protein concentration by resuspending in native PAGE sample buffer (4×) and cathode buffer additive (Invitrogen) according to the manufacturer's instructions.
41|
Load the same amount of proteins for each fraction on a NativePAGE Novex Bis-Tris gel system (3-12%, wt/vol).
42|
Run the gel at 150 V for 110 min according to the supplier's instructions.
43|
Upon completion of electrophoresis, re-equilibrate the gel in water for 5 min and stain it using the Pierce color silver stain kit, according to the manufacturer's instructions. An example of native-PAGE results is shown in Figure 4d , confirming protein separation by HF5 according to MW and hydrodynamic size, detected as the increment in MW in progressive fractions.
The gel shows the presence of very HMW aggregates in fraction 6 of PQ-treated samples but not in the CTR lysate, which is in agreement with the HF5-UV-MALS results (Fig. 4a) .  pause poInt We used native-PAGE on the protein fractions separated by HF5 to prove the suitability of the HF5 method to separate and characterize protein aggregates of different MWs from total cell lysates, as HF5-UV-MALS is not a routine technique for proteome prefractionation. The protein aggregates present in the native-PAGE lanes can be further processed by mass spectrometry for proteomics studies. Continue to flush the system with the carrier solution. Clean the system with cleaning solution, followed by Milli-Q water (1-2 h) and carrier solution (1-2 h), at 0.5-0.6 ml/min
The system seems to be leaking Check the system for possible leaks (continued)
• tIMInG
Step 
antIcIpateD results
With this protocol, the HF5-UV-MALS setup successfully analyzes and fractionates protein aggregates, as found in total cell lysates. The experimental design is set up using PQ-induced carbonylation, which causes the formation of HMW protein aggregates that closely resemble the ones observed in aging and chronic inflammatory or degenerative conditions. In contrast to other currently used methodologies (SEC, FPLC, electrophoresis and SV-AUC), the FFF separation system coupled on-line with UV and MALS detection allows the fractionation of HMW protein aggregates and simultaneous measurement of their MW, r.m.s. radius and molecular conformation ( Fig. 4; tables 2, 3, 5 and 6 ).
The comparison between the results obtained under native conditions and under mild denaturing conditions is reported in tables 2 and 3 (native) and tables 5 and 6 (mild denaturing). The CTR sample and the PQ-treated samples have a common protein range (MW <3.5 × 10 6 Da); however, only the PQ-treated samples contain protein aggregates with higher MW, and their MW upper limit increases with the PQ concentration. The relative amount (%) of the PQ-induced aggregates increases with the PQ molarity (table 2). When separated under denaturing conditions, the relative amount of PQ-induced protein aggregates decreases drastically (table 5) . Their size (expressed as hydrodynamic radius and r.m.s. radius) is also reduced under denaturing conditions. The molecular conformation changes with the PQ molarity (Fig. 4b) toward progressively more compact forms. Under denaturing conditions, the protein aggregates in the 10 mM PQ sample assume an even more compact conformation; i.e., they are sphere-like.
The traditional AF4 (a larger version of HF5) long channel could be used for semipreparative purposes (adjusting the flow rates for the separation); however, we believe that the loss of HMW protein aggregates (owing to nonspecific interaction with the membrane wall) would be significant as compared with the HF5 miniaturized device. The HF5-UV-MALS experimental setup described here allows obtaining the following information: (i) the absolute MW of the PQ-induced aggregates (no standards required), which is a measurement that cannot be accurately attained with any other method; (ii) the r.m.s. radius and molecular conformation of the aggregates, both of which are important factors in determining cellular clearance of the aggregates; (iii) the aggregates' behavior under denaturing conditions, which is important to determine the covalent versus noncovalent nature of the aggregates; and (iv) the relative percentage of cellular aggregates under increasing amount of PQ-induced oxidative stress, which is a measurement that would be extremely useful in monitoring conditions and treatments aimed at decreasing cellular aggregates. 
